Jennifer Venhorst

1.0k total citations
26 papers, 811 citations indexed

About

Jennifer Venhorst is a scholar working on Molecular Biology, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, Jennifer Venhorst has authored 26 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Computational Theory and Mathematics and 6 papers in Pharmacology. Recurrent topics in Jennifer Venhorst's work include Computational Drug Discovery Methods (8 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Receptor Mechanisms and Signaling (5 papers). Jennifer Venhorst is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Receptor Mechanisms and Signaling (5 papers). Jennifer Venhorst collaborates with scholars based in Netherlands, United Kingdom and United States. Jennifer Venhorst's co-authors include Chris G. Kruse, Sara Núñez, Nico Vermeulen, Jan N. M. Commandeur, Antonius ter Laak, Rob Onderwater, Jan Willem Terpstra, Natasja de Bruin, Yoshihiko Funae and Toyoko Hiroi and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Jennifer Venhorst

25 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Venhorst Netherlands 18 395 229 203 118 107 26 811
Dino Montanari Italy 14 382 1.0× 265 1.2× 129 0.6× 89 0.8× 185 1.7× 23 980
Stefanus J. Steyn United States 19 428 1.1× 257 1.1× 390 1.9× 451 3.8× 111 1.0× 38 1.5k
Danni L. Harris United States 22 607 1.5× 87 0.4× 318 1.6× 200 1.7× 140 1.3× 52 1.4k
Cheng Chang United States 14 275 0.7× 137 0.6× 167 0.8× 122 1.0× 58 0.5× 29 747
Spencer S. Ericksen United States 15 399 1.0× 212 0.9× 187 0.9× 81 0.7× 41 0.4× 29 681
Trevor Howe United Kingdom 13 697 1.8× 286 1.2× 177 0.9× 67 0.6× 308 2.9× 24 1.2k
Norman Huebert United States 21 356 0.9× 54 0.2× 176 0.9× 144 1.2× 103 1.0× 40 1.1k
Zdzisław Chilmończyk Poland 20 662 1.7× 184 0.8× 73 0.4× 66 0.6× 372 3.5× 92 1.3k
Scott Oloff United States 11 487 1.2× 561 2.4× 70 0.3× 77 0.7× 168 1.6× 14 1.1k
Simone Braggio Italy 15 214 0.5× 77 0.3× 57 0.3× 55 0.5× 86 0.8× 25 540

Countries citing papers authored by Jennifer Venhorst

Since Specialization
Citations

This map shows the geographic impact of Jennifer Venhorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Venhorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Venhorst more than expected).

Fields of papers citing papers by Jennifer Venhorst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Venhorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Venhorst. The network helps show where Jennifer Venhorst may publish in the future.

Co-authorship network of co-authors of Jennifer Venhorst

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Venhorst. A scholar is included among the top collaborators of Jennifer Venhorst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Venhorst. Jennifer Venhorst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hernández, Manuel A. González, Lars Verschuren, Martien P. M. Caspers, et al.. (2024). Identifying patient subgroups in MASLD and MASH-associated fibrosis: molecular profiles and implications for drug development. Scientific Reports. 14(1). 23362–23362. 4 indexed citations
2.
Venhorst, Jennifer, Roeland Hanemaaijer, Martien P. M. Caspers, et al.. (2024). Integrating text mining with network models for successful target identification: in vitro validation in MASH-induced liver fibrosis. Frontiers in Pharmacology. 15. 1442752–1442752. 2 indexed citations
3.
Venhorst, Jennifer, J.M.B.M. van der Vossen, & Valeria Agamennone. (2022). Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens. Frontiers in Microbiology. 13. 891790–891790. 23 indexed citations
4.
Venhorst, Jennifer, et al.. (2022). Oncostatin M: Risks and Benefits of a Novel Therapeutic Target for Atherosclerosis. Current Drug Targets. 23(14). 1345–1369. 4 indexed citations
5.
Bruin, Natasja de, Arnold van Loevezijn, Karsten Wicke, et al.. (2016). The selective 5-HT 6 receptor antagonist SLV has putative cognitive- and social interaction enhancing properties in rodent models of cognitive impairment. Neurobiology of Learning and Memory. 133. 100–117. 22 indexed citations
6.
Loevezijn, Arnold van, Jennifer Venhorst, Wouter Bakker, et al.. (2016). Optimization of N′-(arylsulfonyl)pyrazoline-1-carboxamidines by exploiting a novel interaction site in the 5-HT6 antagonistic binding pocket. Bioorganic & Medicinal Chemistry Letters. 26(6). 1605–1611. 3 indexed citations
7.
Steeg, Evita van de, et al.. (2015). Generation of Bayesian prediction models for OATP-mediated drug–drug interactions based on inhibition screen of OATP1B1, OATP1B1∗15 and OATP1B3. European Journal of Pharmaceutical Sciences. 70. 29–36. 15 indexed citations
8.
Bruin, Natasja de, Andrew C. McCreary, Arnold van Loevezijn, et al.. (2012). A novel highly selective 5-HT6 receptor antagonist attenuates ethanol and nicotine seeking but does not affect inhibitory response control in Wistar rats. Behavioural Brain Research. 236(1). 157–165. 25 indexed citations
9.
Bruin, Natasja de, Jos Prickaerts, Arnold van Loevezijn, et al.. (2011). Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats. Neurobiology of Learning and Memory. 96(2). 392–402. 54 indexed citations
10.
Loevezijn, Arnold van, Jennifer Venhorst, Wouter Bakker, et al.. (2011). N′-(Arylsulfonyl)pyrazoline-1-carboxamidines as Novel, Neutral 5-Hydroxytryptamine 6 Receptor (5-HT6R) Antagonists with Unique Structural Features. Journal of Medicinal Chemistry. 54(20). 7030–7054. 44 indexed citations
11.
Lange, Jos H.M., Jennifer Venhorst, Maria J. P. van Dongen, et al.. (2011). Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors. European Journal of Medicinal Chemistry. 46(10). 4808–4819. 21 indexed citations
12.
Venhorst, Jennifer, et al.. (2010). Assessment of a Novel Scoring Method Based on Solvent Accessible Surface Area Descriptors. Journal of Chemical Information and Modeling. 50(4). 480–486. 18 indexed citations
13.
Venhorst, Jennifer, Martijn Rooseboom, Nico Vermeulen, & Jan N. M. Commandeur. (2003). Studies on the inhibition of human cytochromes P450 by selenocysteine Se -conjugates. Xenobiotica. 33(1). 57–72. 7 indexed citations
14.
Venhorst, Jennifer, Antonius ter Laak, Jan N. M. Commandeur, et al.. (2002). Homology Modeling of Rat and Human Cytochrome P450 2D (CYP2D) Isoforms and Computational Rationalization of Experimental Ligand-Binding Specificities. Journal of Medicinal Chemistry. 46(1). 74–86. 92 indexed citations
15.
Layton, Judith E., Nathan E. Hall, Fiona Connell, Jennifer Venhorst, & Herbert Treutlein. (2001). Identification of Ligand-binding Site III on the Immunoglobulin-like Domain of the Granulocyte Colony-stimulating Factor Receptor. Journal of Biological Chemistry. 276(39). 36779–36787. 38 indexed citations
16.
Venhorst, Jennifer, Rob Onderwater, John H.N. Meerman, Jan N. M. Commandeur, & Nico Vermeulen. (2000). Influence of N-Substitution of 7-Methoxy-4-(aminomethyl)-coumarin on Cytochrome P450 Metabolism and Selectivity. Drug Metabolism and Disposition. 28(12). 1524–1532. 36 indexed citations
17.
Venhorst, Jennifer, Rob Onderwater, John H.N. Meerman, Nico Vermeulen, & Jan N. M. Commandeur. (2000). Evaluation of a novel high-throughput assay for cytochrome P450 2D6 using 7-methoxy-4-(aminomethyl)-coumarin. European Journal of Pharmaceutical Sciences. 12(2). 151–158. 19 indexed citations
18.
Onderwater, Rob, Jennifer Venhorst, Jan N. M. Commandeur, & Nico Vermeulen. (1999). Design, Synthesis, and Characterization of 7-Methoxy-4-(aminomethyl)coumarin as a Novel and Selective Cytochrome P450 2D6 Substrate Suitable for High-Throughput Screening. Chemical Research in Toxicology. 12(7). 555–559. 50 indexed citations
19.
Zwart, L.L. de, et al.. (1997). Simultaneous determination of eight lipid peroxidation degradation products in urine of rats treated with carbon tetrachloride using gas chromatography with electron-capture detection. Journal of Chromatography B Biomedical Sciences and Applications. 694(2). 277–287. 45 indexed citations
20.
Laak, Antonius ter, Jennifer Venhorst, Gabriëlle M. Donné-Op den Kelder, & H. Timmerman. (1995). The Histamine H1-Receptor Antagonist Binding Site. A Stereoselective Pharmacophoric Model Based upon (Semi-)Rigid H1-Antagonists and Including a Known Interaction Site on the Receptor. Journal of Medicinal Chemistry. 38(17). 3351–3360. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026